Jessica Richardson1, Abhishek Datta2, Jacek Dmochowski3, Lucas C Parra3, Julius Fridriksson1. 1. Department of Communication Sciences & Disorders, The University of South Carolina, Columbia, SC, USA. 2. Soterix Medical, Inc., New York, NY, USA. 3. Department of Biomedical Engineering, The City College of New York of CUNY, New York, NY, USA.
Abstract
BACKGROUND:Transcranial direct current stimulation (tDCS) enhances treatment outcomes post-stroke. Feasibility and tolerability of high-definition (HD) tDCS (a technique that increases current focality and intensity) for consecutive weekdays as an adjuvant to behavioral treatment in a clinical population has not been demonstrated. OBJECTIVE: To determine HD-tDCS feasibility outcomes: 1) ability to implement study as designed, 2) acceptability of repeated HD-tDCS administration to patients, and 3) preliminary efficacy. METHODS:Eight patients with chronic post-stroke aphasia participated in a randomized crossover trial with two arms: conventional sponge-based (CS) tDCS and HD-tDCS. Computerized anomia treatment was administered for five consecutive days during each treatment arm. RESULTS: Individualized modeling/targeting procedures and an 8-channel HD-tDCS device were developed. CS-tDCS and HD-tDCS were comparable in terms of implementation, acceptability, and outcomes. Naming accuracy and response time improved for both stimulation conditions. Change in accuracy of trained items was numerically higher (but not statistically significant) for HD-tDCS compared to CS-tDCS for most patients. CONCLUSIONS: Regarding feasibility, HD-tDCS treatment studies can be implemented when designed similarly to documented CS-tDCS studies. HD-tDCS is likely to be acceptable to patients and clinicians. Preliminary efficacy data suggest that HD-tDCS effects, using only 4 electrodes, are at least comparable to CS-tDCS.
RCT Entities:
BACKGROUND: Transcranial direct current stimulation (tDCS) enhances treatment outcomes post-stroke. Feasibility and tolerability of high-definition (HD) tDCS (a technique that increases current focality and intensity) for consecutive weekdays as an adjuvant to behavioral treatment in a clinical population has not been demonstrated. OBJECTIVE: To determine HD-tDCS feasibility outcomes: 1) ability to implement study as designed, 2) acceptability of repeated HD-tDCS administration to patients, and 3) preliminary efficacy. METHODS: Eight patients with chronic post-stroke aphasia participated in a randomized crossover trial with two arms: conventional sponge-based (CS) tDCS and HD-tDCS. Computerized anomia treatment was administered for five consecutive days during each treatment arm. RESULTS: Individualized modeling/targeting procedures and an 8-channel HD-tDCS device were developed. CS-tDCS and HD-tDCS were comparable in terms of implementation, acceptability, and outcomes. Naming accuracy and response time improved for both stimulation conditions. Change in accuracy of trained items was numerically higher (but not statistically significant) for HD-tDCS compared to CS-tDCS for most patients. CONCLUSIONS: Regarding feasibility, HD-tDCS treatment studies can be implemented when designed similarly to documented CS-tDCS studies. HD-tDCS is likely to be acceptable to patients and clinicians. Preliminary efficacy data suggest that HD-tDCS effects, using only 4 electrodes, are at least comparable to CS-tDCS.
Authors: Mariana E Mendonca; Marcus B Santana; Abrahão F Baptista; Abhishek Datta; Marom Bikson; Felipe Fregni; Cintia P Araujo Journal: J Pain Date: 2011-04-15 Impact factor: 5.820
Authors: Siobhán Harty; Ian H Robertson; Carlo Miniussi; Owen C Sheehy; Ciara A Devine; Sarahjane McCreery; Redmond G O'Connell Journal: J Neurosci Date: 2014-03-05 Impact factor: 6.167
Authors: Charlotte J Stagg; Jonathan G Best; Mary C Stephenson; Jacinta O'Shea; Marzena Wylezinska; Z Tamas Kincses; Peter G Morris; Paul M Matthews; Heidi Johansen-Berg Journal: J Neurosci Date: 2009-04-22 Impact factor: 6.167
Authors: Christopher A Turski; Alanna Kessler-Jones; Clara Chow; Bruce Hermann; David Hsu; Jana Jones; Susanne K Seeger; Rick Chappell; Melanie Boly; Chrysanthy Ikonomidou Journal: Restor Neurol Neurosci Date: 2017 Impact factor: 2.406
Authors: Jacek P Dmochowski; Abhishek Datta; Yu Huang; Jessica D Richardson; Marom Bikson; Julius Fridriksson; Lucas C Parra Journal: Neuroimage Date: 2013-03-05 Impact factor: 6.556
Authors: Jinyi Hung; Ashley Bauer; Murray Grossman; Roy H Hamilton; H B Coslett; Jamie Reilly Journal: Front Hum Neurosci Date: 2017-05-16 Impact factor: 3.169
Authors: Bruce Crosson; Amy D Rodriguez; David Copland; Julius Fridriksson; Lisa C Krishnamurthy; Marcus Meinzer; Anastasia M Raymer; Venkatagiri Krishnamurthy; Alexander P Leff Journal: J Neurol Neurosurg Psychiatry Date: 2019-05-04 Impact factor: 10.154